Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13D/A - Leap Therapeutics, Inc. | StockGist | StockGist

Companies
LPTX
SCHEDULE 13D/A

Home Top Movers Companies Concepts

Home Filings LPTXSCHEDULE 13D/A

SCHEDULE 13D/A

Beneficial Ownership

Amendment

Leap Therapeutics, Inc.

Filed Oct 31, 2024

Accepted Oct 30, 2024, 8:00 PM ET

CIK 0001509745

View on SEC.gov Company Profile

Beneficial Ownership Report

Active Investment

Shares Owned

1,215,306

Reporting Person

LEAP THERAPEUTICS, INC.

Person Type

CO

Event Date

Oct 31, 2024

CUSIP: 52187K200

Amendment History

5 filings

SCHEDULE 13D
Original
Oct 16, 20250002085726-25-000004
SCHEDULE 13D/A
Amendment 1
Viewing
Oct 31, 20240001651308-24-000145
SCHEDULE 13D/A
Amendment 2
Viewing
Oct 31, 20240001651308-24-000145
SCHEDULE 13D/A
Amendment 3
Nov 21, 20250002085726-25-000008
SCHEDULE 13D/A
Amendment 4
Latest
Nov 21, 20250002085726-25-000008

Key Facts

Shares Owned

1,215,306

Recent Filings

Leap Therapeutics, Inc.3 weeks ago

Leap Therapeutics, Inc.1 months ago

Leap Therapeutics, Inc.3 months ago

Leap Therapeutics, Inc.3 months ago

Leap Therapeutics, Inc.3 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice